Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jincheng Yang
A Survey of the FDA’s Adverse Event Reporting System Database Concerning Urogenital Tract Infections and Sodium Glucose Cotransporter‐2 Inhibitor Use
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Use of Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections in Type 2 Diabetes Patients: A Systematic Review
Revista da Associacao Medica Brasileira
Medicine
Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis
European Scientific Journal ESJ
Clinical Risk Factors Predicting Genital Fungal Infections With Sodium–glucose Cotransporter 2 Inhibitor Treatment: The ABCD Nationwide Dapagliflozin Audit
Primary Care Diabetes
Internal Medicine
Nutrition
Endocrinology
Dietetics
Metabolism
Diabetes
Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes
Therapeutics and Clinical Risk Management
The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, With Dapagliflozin and Ipragliflozin
Pharmaceutics
Pharmaceutical Science
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Journal of Clinical Medicine Research
Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
Drugs - Real World Outcomes
Pharmacology
